Nebuflow, a University of Glasgow medical spin-out, is developing the next generation of nebulisers. Its patented aerosol formation technology allows for the efficient delivery of hard-to-nebulise drugs to the lungs. As such, it is made for both existing formulations and emerging novel high-value therapeutics such as biologics, nanomedicines, and vaccines — enabling medical professionals to …